Hyunmi Choi

Hyunmi Choi

Auto-generated profile, based on publicly available information

Hyunmi Choi

Department of Neurology Vagelos College of Physicians and Surgeons, Columbia University New York New York USA

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 December 2008 in JAMA
Verified
Journal Article
Open access
PDF file
HCHyunmi Choi
Hyunmi Choi
RSRandall L. Sell
Randall L. Sell
LLLeslie Lenert
Leslie Lenert
PMPeter Muennig
Peter Muennig
RGRobert R. Goodman
Robert R. Goodman
JWJohn B. Wong
John B. Wong
Epilepsy accounts for 1% of the global burden of disease due to disability, affecting 0.5% to 1% of the world's population.1 Despite currently available antiepileptic drugs, 20% to 40% of all patients with epilepsy remain refractory to medical management.2-5 For such patients, epilepsy surgery still remains underused worldwide.6-8 Few patients are referred for epilepsy surgery evaluation, and these referrals commonly occur late in the course of their disease, after 20 years of seizures.9-11 Temporal lobe epilepsy is the most common form of epilepsy12 and the most likely to be medically refractory.13

1 October 2009 in Epilepsy Research
Verified
Journal Article
Closed access
HCHyunmi Choi
Hyunmi Choi
RCRichard Carlino
Richard Carlino
GHGary A. Heiman
Gary A. Heiman
WHW. Allen Hauser
W. Allen Hauser
FGFrank G. Gilliam
Frank G. Gilliam

28 February 2017 in Neurology
Verified
Journal Article
Closed access
PDF file
HCHyunmi Choi
Hyunmi Choi
APAlison Pack
Alison Pack
MEMitchell S.V. Elkind
Mitchell S.V. Elkind
WLW.T. Longstreth
W.T. Longstreth
TTThanh G.N. Ton
Thanh G.N. Ton
FOFrankline Onchiri
Frankline Onchiri
Objective: To determine the prevalence, incidence, and predictors of epilepsy among older adults in the Cardiovascular Health Study (CHS). Methods: We analyzed data prospectively collected in CHS and merged with data from outpatient Medicare administrative claims. We identified cases with epilepsy using self-report, antiepileptic medication, hospitalization discharge ICD-9 codes, and outpatient Medicare ICD-9 codes. We used Cox proportional hazards regression to identify factors independently associated with incident epilepsy. Results: At baseline, 42% of the 5,888 participants were men and 84% were white. At enrollment, 3.7% (215 of 5,888) met the criteria for prevalent epilepsy. During 14 years of follow-up totaling 48,651 person-years, 120 participants met the criteria for incident epilepsy, yielding an incidence rate of 2.47 per 1,000 person-years. The period prevalence of epilepsy by the end of follow-up was 5.7% (335 of 5,888). Epilepsy incidence rates were significantly higher among blacks than nonblacks: 4.44 vs 2.17 per 1,000 person-years (p < 0.001). In multivariable analyses, risk of incident epilepsy was significantly higher among blacks compared to nonblacks (hazard ratio [HR] 4.04, 95% confidence interval [CI] 1.99–8.17), those 75 to 79 compared to those 65 to 69 years of age (HR 2.07, 95% CI 1.21–3.55), and those with history of stroke (HR 3.49, 95% CI 1.37–8.88). Conclusions: Epilepsy in older adults in the United States was common. Blacks, the very old, and those with history of stroke have a higher risk of incident epilepsy. The association with race remains unexplained.

1 July 2015 in Seizure: European Journal of Epilepsy
Verified
Journal Article
Closed access
AJAsif Javed
Asif Javed
BCBrian Cohen
Brian Cohen
KDKamil Detyniecki
Kamil Detyniecki
LHLawrence J. Hirsch
Lawrence J. Hirsch
ALAlexander Legge
Alexander Legge
HCHyunmi Choi
Hyunmi Choi

6 June 2016 in Epilepsia
Verified
Journal Article
Closed access
PDF file
HCHyunmi Choi
Hyunmi Choi
MHMatthew J. Hayat
Matthew J. Hayat
RZRuiqi Zhang
Ruiqi Zhang
LHLawrence J. Hirsch
Lawrence J. Hirsch
CBCarl W. Bazil
Carl W. Bazil
GHGary A. Heiman
Gary A. Heiman

28 July 2008 in Epilepsia
Verified
Journal Article
Open access
PDF file
HCHyunmi Choi
Hyunmi Choi
GHGary A. Heiman
Gary A. Heiman
DPDionysis Pandis
Dionysis Pandis
JCJulio Cantero
Julio Cantero
SRStanley R. Resor
Stanley R. Resor
WHW. Allen Hauser
W. Allen Hauser
Summary: Purpose: To investigate the cumulative probabilities of ≥12 month seizure remission and seizure relapse following remission, and to test the associations of clinical characteristics with these two study end points in a prevalence cohort of intractable adult epilepsy patients during medical management. Methods: A retrospective cohort study of intractable epilepsy patients seen in 2001 at a single center was conducted. Kaplan–Meier analysis was used to estimate the cumulative probabilities of seizure remission and subsequent seizure relapse. Cox proportional hazards models were used to estimate the association (1) between clinical factors and ≥12 month seizure remission and (2) between clinical factors and seizure relapse following remission. Results: One hundred eighty‐seven subjects met the eligibility criteria for intractable epilepsy. The estimate of probability of remission was about 4% per year. Seizure remission was temporary for some individuals, as 5 out of 20 subjects with remission ultimately relapsed. No clinical factors predicted the likelihood of achieving ≥12 month seizure remission or subsequent seizure relapse. Discussion: Some people with intractable epilepsy achieve ≥12 month seizure remission during medical treatment. Remission, however, is only temporary for some individuals. We were unable to identify clear predictors for remission.